Anxiety and Depression Treatment Market By Offerings (Products (Benzodiazepine, Buspirone, Beta Blockers (Propranolol, Atenolol, Others), Others), Solutions, Services (Psychotherapy (Cognitive Behavioural Therapy (CBT), Interpersonal Therapy (IPT), Psychodynamic Therapy, Supportive Therapy, Others), Others); By Treatment Duration (Short Term, Long Term); By Form (Anxiety (Panic Disorder, Social Anxiety Disorder, Obsessive Compulsive Disorder, Generalized Anxiety Disorder, Others), Depression (Major Depression, Persistent Depressive Disorder, Bipolar Disorder, Others); By Distribution Channel (Online, Offline (Hospitals/Clinics, Wellness Centers, Research Centers, Others)); By Age Group (Children, Adults, Senior Citizens ); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Spain, Germany, Italy, Nordic Countries , Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Singapore, Philippines, Indonesia, Thailand, Malaysia, Vietnam, Rest of Southeast Asia), Brazil, Argentina, Rest of Latin America, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2020 - 2028

Report ID :AMI-760 | Category : Manufacturing & Construction | Published Date : December, 2020 | Pages : 402 | Format :PDF

Industry Trends

Depression has affected 350 million people worldwide and is projected to rise due to the upward trend in the acceptance of sedentary lifestyles. Depression is the world's second leading cause of impairment, increasing the need in the near future for the production of new drugs. In the global healthcare scenario, the prevalence of depression and anxiety has continued to increase. Such an increase in depression and anxiety occurrence rates has led to an emphasis on the global healthcare situation for the treatment of these disorders. In the global scenario, more than 300 million people of all ages suffered from depression in the year 2018. In the same year, there were 800,000 cases of suicides, the reasons behind the same were mostly depression and anxiety disorders. One of the major factors driving the Anxiety and Depression Treatment Market is this increase in the incidence rate of depression and anxiety.

A daunting part of practising medicine in the primary care environment is to better identify and treat patients with anxiety, depression, or both. Instead of classic psychological symptoms, patients frequently exhibit somatic complaints. Moreover, there is a substantial correlation between anxiety and depression. Anxiety and depression are major public health issues that affect a broad segment of the general population and account for multibillion-dollar spending directly related to health care and hospitalizations and indirectly related to morbidity and mortality. Depression and anxiety complaints are very common among adult patients seeking treatment in primary care settings, and the majority of drugs for these conditions are prescribed by primary care providers.

There are various causes for depression and anxiety, but they usually occur together. They have similar therapies as well. With psychiatric treatment medicine such as antidepressants symptoms in both conditions typically improve. Changes in lifestyles can help to reduce anxiety and depression.

Increased demand for antidepressants is leading to growth in adoption of these drugs and patient recovery due to reduced side effects associated with these drugs and rising levels of consumer knowledge. However, the rising rate of medication withdrawals and the launch of generic versions on a wide scale, patent expiration of most medications is expected to curb the growth of the demand for anxiety disorders and depression treatment in the coming years.

The dry pipeline for new drugs, drug-resistant psychiatric disorders and rising numbers of various generic drugs may hinder the growth of the demand for anxiety disorders and depression care. Also, it is expected that the launch of generic biosimilars by key players as a cost-effective alternative would hamper the growth of this Anxiety and Depression Treatment Market.

Market development is positively influenced by the existence of favourable reimbursement policies in developed regions for drugs and therapies. This has a positive effect on the market for medication for anxiety disorders. Help and education play an important role in the management of anxiety disorders alongside medications. Developing nations are coping tremendously with mental disorders for instance, every year in the U.S., about 10 million individuals suffer from mental illness. In addition, the growth of the Anxiety and Depression Treatment Market is further boosted by growing recognition and the increasing commitment of government organisations to alleviating the burden of disease. Global anxiety and depression treatment market was estimated to be US$ 18.5 Bn in 2019 and is expected to grow at a CAGR of 11.7% during the forecast period (2020-2028).

By Offerings

Anxiety and Depression Treatment Market participants have been working with public health entities in providing treatment for anxiety and depression to various patients. The treatment plan majorly includes medications, solutions, and services. Medications ranging from antidepressants, benzodiazepines, beta blockers and buspirone, among others. The medications are observed to impact the various transmitters that can be responsible for the onset of depression or help in reducing the impact of the mental disorders for the users. Software have been responsible for creating a channel between the professionals and the users for their consultations, and data transfer applications. Psychotherapy has been observed to be the notable offering in the market and is observed to have a higher rate of effectiveness across a wide range of users. The presence of the service in the short term and long term durations is expected to aid the growth of the market across various regions.

By Treatment Duration

The treatment for anxiety and depression is majorly dependent on the onset characteristics of the disorder for the patient. The medical professionals assess the severity of the disorder for various patients. This helps them in creating tailor made treatment plans for several patients. The patients are them provided with short term and long term treatment plans that would help in reducing the effects of disorders including anxiety and depression. Long term treatment duration is observed to be a greater revenue contributor for the Anxiety and Depression Treatment Market owing to higher investments from users in the treatment process.

By Form

Anxiety and depression are observed to be prevalent among various patients in an individual and mixed form over the years. Apart from the umbrella terms, there is an observation of disorders that are ranging from panic disorder, social anxiety disorder to persistent depressive disorder that have been prevalent across several countries. Increasing studies on the forms of mental disorders have been important for medical professionals in their process for developing treatment plans for a wide range of patients coming from numerous countries and from various age groups. The increasing number of forms in the anxiety and depression categories are also helping governing authorities to ramp up their awareness initiatives in order to reduce the impact of the disorders on the overall health of the general population in the near future. These efforts are expected to help in the development of comprehensive treatment processes which would lead to optimal recovery for the patients.

By Distribution Channel

The treatment for anxiety and depression has been designed to provide optimal relief for the patients across the world. Depending on the availability of services and solutions, treatment for anxiety and depression is imparted through the online and offline mode. Offline providers including hospitals/clinics, wellness centers and research centers have been responsible for offering in-person help to patients through psychotherapy and medications. In addition to this, in-home care services are also being developed that can help patients in their treatment phase. Online services were traditionally responsible to help patients during the procurement of medications prescribed by their medical professionals. With the advancements in mHealth and internet, various market participants have introduced online consultations and therapy sessions for several patients. In the conditions of lockdowns initiated due to the concerns related to the novel coronavirus (COVID-19), online services have been observed to receive significantly more requests for psychodynamic consultations and therapies. These factors are expected to help the market gain a wider customer base on the global scale.

By Age Group

The cases related to anxiety and depression have been observed to include patients across various age groups. Countries have been observing growth in the cases throughout the numerous age groups owing to the several reasons leading primarily towards mental disorders including anxiety and depression. Changes in the living conditions have been observed to be a major reason for the prevalence of mental disorders among children and adults. Senior citizens and adults contribute to a higher number of cases related to anxiety and depression on the global scale. In addition to this, the senior citizens are observed to suffer from anxiety and depression owing to reasons ranging from the relation between physical conditions to mental conditions, psychological trauma to substance issues among others. These factors are being studied in detail by medical researchers in order to develop an optimized treatment plan for the patients.

By Region

The awareness regarding anxiety and depression cases has been growing across various countries. The penetration of medical services has been observed to be more significant in developed countries as compared to developing countries. This has been responsible for the increasing prevalence of services and solutions related to anxiety and depression in various countries that are considered in the developed stages. Countries across regions including North America and Europe have shown positive trends in terms of the deployment of treatment solutions and services for patients suffering from anxiety and depression. Conducive initiatives from public and private organizations regarding the awareness for the various forms of mental disorders and the required treatment measures for the same have led to increasing adoption of Anxiety and Depression Treatment Market offerings across various regions. The region of Asia Pacific is expected to be a major adopter for market offerings owing to a steady rise in instances related to mental disorders along with initiatives undertaken by governing authorities across the countries for strengthening the healthcare infrastructure. These factors are expected to aid the growth of the Anxiety and Depression Treatment Market over the forecast period across various regions.

Anxiety and Depression Treatment Market Revenue & Forecast, (US$ Million), 2015 – 2028

Competitive Landscape

The report provides both, qualitative and quantitative research of anxiety and depression treatment market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.

Some of the players operating in the anxiety and depression treatment market are Actiza Pharmaceutical Private Limited, Amwell, ANI Pharmaceuticals, Inc., BetterHelp, eTherapyPro.com, F. Hoffmann-La Roche Ltd, Groop Internet Platform, Inc. (Talkspace), MDLIVE Inc., Pfizer Inc., Teva Pharmaceuticals USA, Inc., and The Ross Center, among others.

Anxiety and Depression Treatment Market:

By Offerings

Products
Benzodiazepine
Buspirone
Beta Blockers
- Propranolol
- Atenolol
- Others
Others
Solutions
Services
Psychotherapy
- Cognitive Behavioural Therapy (CBT)
- Interpersonal Therapy (IPT)
- Psychodynamic Therapy
- Supportive Therapy
- Others
Others

By Treatment Duration

Short Term
Long Term

By Form

Anxiety
- Panic Disorder
- Social Anxiety Disorder
- Obsessive Compulsive Disorder
- Generalized Anxiety Disorder
- Others
Depression
- Major Depression
- Persistent Depressive Disorder
- Bipolar Disorder
- Others

By Distribution Channel

Online
Offline
- Hospitals/Clinics
- Wellness Centers
- Research Centers
- Others

By Age Group

Children
Adults
Senior Citizens

By Region

North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
  - Denmark
  - Finland
  - Iceland
  - Sweden
  - Norway
- Benelux Union
  - Belgium
  - The Netherlands
  - Luxembourg
Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
  - Indonesia
  - Thailand
  - Malaysia
  - Singapore
  - Rest of Southeast Asia
Rest of Asia Pacific
Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America

Table of Contents

1. Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2015 - 2018

1.2.2. Base Year: 2019

1.2.3. Forecast Years: 2020 – 2028

2. Key Target Audiences

3. Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4. Recommendations and Insights from AMI’s Perspective**

5. Holistic Overview of Anxiety and Depression Treatment Market

6. Market Synopsis: Anxiety and Depression Treatment Market

7. Anxiety and Depression Treatment Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.3. Trends in Anxiety and Depression Treatment Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Anxiety and Depression Treatment Market

7.6. Porter’s Five Force Analysis

7.7. Impact of COVID-19 on Global Anxiety and Depression Treatment Market

8. Global Anxiety and Depression Treatment Market Analysis and Forecasts, 2020 – 2028

8.1. Overview

8.1.1. Global Anxiety and Depression Treatment Market Revenue (US$ Mn)

8.2. Global Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

8.2.1. Products (Definition, Market Estimation and Penetration, 2015 – 2019, Market Estimation (2015 – 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Benzodiazepine, Buspirone, Beta Blockers, Others)

8.2.1.1. Benzodiazepine

8.2.1.2. Buspirone

8.2.1.3. Beta Blockers

8.2.1.3.1. Propranolol

8.2.1.3.2. Atenolol

8.2.1.3.3. Others

8.2.1.4. Others

8.2.2. Solutions

8.2.2.1. Definition

8.2.2.2. Market Estimation and Penetration, 2015 – 2019

8.2.2.3. Market Forecast, 2020 – 2028

8.2.2.4. Compound Annual Growth Rate (CAGR)

8.2.2.5. Regional Bifurcation

8.2.2.5.1. North America

8.2.2.5.1.1. Market Estimation, 2015 – 2019

8.2.2.5.1.2. Market Forecast, 2020 – 2028

8.2.2.5.2. Europe

8.2.2.5.2.1. Market Estimation, 2015 – 2019

8.2.2.5.2.2. Market Forecast, 2020 – 2028

8.2.2.5.3. Asia Pacific

8.2.2.5.3.1. Market Estimation, 2015 – 2019

8.2.2.5.3.2. Market Forecast, 2020 – 2028

8.2.2.5.4. Middle East and Africa

8.2.2.5.4.1. Market Estimation, 2015 – 2019

8.2.2.5.4.2. Market Forecast, 2020 – 2028

8.2.2.5.5. Latin America

8.2.2.5.5.1. Market Estimation, 2015 – 2019

8.2.2.5.5.2. Market Forecast, 2020 – 2028

8.2.3. Services (Definition, Market Estimation and Penetration, 2015 – 2019, Market Estimation (2015 – 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Psychotherapy, Others)

8.2.3.1. Psychotherapy

8.2.3.1.1. Cognitive Behavioural Therapy (CBT)

8.2.3.1.2. Interpersonal Therapy (IPT)

8.2.3.1.3. Psychodynamic Therapy

8.2.3.1.4. Supportive Therapy

8.2.3.1.5. Others

8.2.3.2. Others

8.3. Key Segment for Channeling Investments

8.3.1. By Offerings

9. Global Anxiety and Depression Treatment Market Analysis and Forecasts, 2020 – 2028

9.1. Overview

9.2. Global Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

9.2.1. Short Term

9.2.1.1. Definition

9.2.1.2. Market Estimation and Penetration, 2015 – 2019

9.2.1.3. Market Forecast, 2020 – 2028

9.2.1.4. Compound Annual Growth Rate (CAGR)

9.2.1.5. Regional Bifurcation

9.2.1.5.1. North America

9.2.1.5.1.1. Market Estimation, 2015 – 2019

9.2.1.5.1.2. Market Forecast, 2020 – 2028

9.2.1.5.2. Europe

9.2.1.5.2.1. Market Estimation, 2015 – 2019

9.2.1.5.2.2. Market Forecast, 2020 – 2028

9.2.1.5.3. Asia Pacific

9.2.1.5.3.1. Market Estimation, 2015 – 2019

9.2.1.5.3.2. Market Forecast, 2020 – 2028

9.2.1.5.4. Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2015 – 2019

9.2.1.5.4.2. Market Forecast, 2020 – 2028

9.2.1.5.5. Latin America

9.2.1.5.5.1. Market Estimation, 2015 – 2019

9.2.1.5.5.2. Market Forecast, 2020 – 2028

9.2.2. Long Term

9.2.2.1. Definition

9.2.2.2. Market Estimation and Penetration, 2015 – 2019

9.2.2.3. Market Forecast, 2020 – 2028

9.2.2.4. Compound Annual Growth Rate (CAGR)

9.2.2.5. Regional Bifurcation

9.2.2.5.1. North America

9.2.2.5.1.1. Market Estimation, 2015 – 2019

9.2.2.5.1.2. Market Forecast, 2020 – 2028

9.2.2.5.2. Europe

9.2.2.5.2.1. Market Estimation, 2015 – 2019

9.2.2.5.2.2. Market Forecast, 2020 – 2028

9.2.2.5.3. Asia Pacific

9.2.2.5.3.1. Market Estimation, 2015 – 2019

9.2.2.5.3.2. Market Forecast, 2020 – 2028

9.2.2.5.4. Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2015 – 2019

9.2.2.5.4.2. Market Forecast, 2020 – 2028

9.2.2.5.5. Latin America

9.2.2.5.5.1. Market Estimation, 2015 – 2019

9.2.2.5.5.2. Market Forecast, 2020 – 2028

9.3. Key Segment for Channeling Investments

9.3.1. By Treatment Duration

10. Global Anxiety and Depression Treatment Market Analysis and Forecasts, 2020 – 2028

10.1. Overview

10.2. Global Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

10.2.1. Anxiety (Definition, Market Estimation and Penetration, 2015 – 2019, Market Estimation (2015 – 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Panic Disorder, Social Anxiety Disorder, Obsessive Compulsive Disorder, Generalized Anxiety Disorder, Others)

10.2.1.1. Panic Disorder

10.2.1.2. Social Anxiety Disorder

10.2.1.3. Obsessive Compulsive Disorder

10.2.1.4. Generalized Anxiety Disorder

10.2.1.5. Others

10.2.2. Depression (Definition, Market Estimation and Penetration, 2015 – 2019, Market Estimation (2015 – 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Major Depression, Persistent Depressive Disorder, Bipolar Disorder, Others)

10.2.2.1. Major Depression

10.2.2.2. Persistent Depressive Disorder

10.2.2.3. Bipolar Disorder

10.2.2.4. Others

10.3. Key Segment for Channeling Investments

10.3.1. By Form

11. Global Anxiety and Depression Treatment Market Analysis and Forecasts, 2020 – 2028

11.1. Overview

11.2. Global Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

11.2.1. Online

11.2.1.1. Definition

11.2.1.2. Market Estimation and Penetration, 2015 – 2019

11.2.1.3. Market Forecast, 2020 – 2028

11.2.1.4. Compound Annual Growth Rate (CAGR)

11.2.1.5. Regional Bifurcation

11.2.1.5.1. North America

11.2.1.5.1.1. Market Estimation, 2015 – 2019

11.2.1.5.1.2. Market Forecast, 2020 – 2028

11.2.1.5.2. Europe

11.2.1.5.2.1. Market Estimation, 2015 – 2019

11.2.1.5.2.2. Market Forecast, 2020 – 2028

11.2.1.5.3. Asia Pacific

11.2.1.5.3.1. Market Estimation, 2015 – 2019

11.2.1.5.3.2. Market Forecast, 2020 – 2028

11.2.1.5.4. Middle East and Africa

11.2.1.5.4.1. Market Estimation, 2015 – 2019

11.2.1.5.4.2. Market Forecast, 2020 – 2028

11.2.1.5.5. Latin America

11.2.1.5.5.1. Market Estimation, 2015 – 2019

11.2.1.5.5.2. Market Forecast, 2020 – 2028

11.2.2. Offline (Definition, Market Estimation and Penetration, 2015 – 2019, Market Estimation (2015 – 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Hospitals/Clinics, Wellness Centers, Research Centers, Others)

11.2.2.1. Hospitals/Clinics

11.2.2.2. Wellness Centers

11.2.2.3. Research Centers

11.2.2.4. Others

11.3. Key Segment for Channeling Investments

11.3.1. By Distribution Channel

12. Global Anxiety and Depression Treatment Market Analysis and Forecasts, 2020 – 2028

12.1. Overview

12.2. Global Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

12.2.1. Children

12.2.1.1. Definition

12.2.1.2. Market Estimation and Penetration, 2015 – 2019

12.2.1.3. Market Forecast, 2020 – 2028

12.2.1.4. Compound Annual Growth Rate (CAGR)

12.2.1.5. Regional Bifurcation

12.2.1.5.1. North America

12.2.1.5.1.1. Market Estimation, 2015 – 2019

12.2.1.5.1.2. Market Forecast, 2020 – 2028

12.2.1.5.2. Europe

12.2.1.5.2.1. Market Estimation, 2015 – 2019

12.2.1.5.2.2. Market Forecast, 2020 – 2028

12.2.1.5.3. Asia Pacific

12.2.1.5.3.1. Market Estimation, 2015 – 2019

12.2.1.5.3.2. Market Forecast, 2020 – 2028

12.2.1.5.4. Middle East and Africa

12.2.1.5.4.1. Market Estimation, 2015 – 2019

12.2.1.5.4.2. Market Forecast, 2020 – 2028

12.2.1.5.5. Latin America

12.2.1.5.5.1. Market Estimation, 2015 – 2019

12.2.1.5.5.2. Market Forecast, 2020 – 2028

12.2.2. Adults

12.2.2.1. Definition

12.2.2.2. Market Estimation and Penetration, 2015 – 2019

12.2.2.3. Market Forecast, 2020 – 2028

12.2.2.4. Compound Annual Growth Rate (CAGR)

12.2.2.5. Regional Bifurcation

12.2.2.5.1. North America

12.2.2.5.1.1. Market Estimation, 2015 – 2019

12.2.2.5.1.2. Market Forecast, 2020 – 2028

12.2.2.5.2. Europe

12.2.2.5.2.1. Market Estimation, 2015 – 2019

12.2.2.5.2.2. Market Forecast, 2020 – 2028

12.2.2.5.3. Asia Pacific

12.2.2.5.3.1. Market Estimation, 2015 – 2019

12.2.2.5.3.2. Market Forecast, 2020 – 2028

12.2.2.5.4. Middle East and Africa

12.2.2.5.4.1. Market Estimation, 2015 – 2019

12.2.2.5.4.2. Market Forecast, 2020 – 2028

12.2.2.5.5. Latin America

12.2.2.5.5.1. Market Estimation, 2015 – 2019

12.2.2.5.5.2. Market Forecast, 2020 – 2028

12.2.3. Senior Citizens

12.2.3.1. Definition

12.2.3.2. Market Estimation and Penetration, 2015 – 2019

12.2.3.3. Market Forecast, 2020 – 2028

12.2.3.4. Compound Annual Growth Rate (CAGR)

12.2.3.5. Regional Bifurcation

12.2.3.5.1. North America

12.2.3.5.1.1. Market Estimation, 2015 – 2019

12.2.3.5.1.2. Market Forecast, 2020 – 2028

12.2.3.5.2. Europe

12.2.3.5.2.1. Market Estimation, 2015 – 2019

12.2.3.5.2.2. Market Forecast, 2020 – 2028

12.2.3.5.3. Asia Pacific

12.2.3.5.3.1. Market Estimation, 2015 – 2019

12.2.3.5.3.2. Market Forecast, 2020 – 2028

12.2.3.5.4. Middle East and Africa

12.2.3.5.4.1. Market Estimation, 2015 – 2019

12.2.3.5.4.2. Market Forecast, 2020 – 2028

12.2.3.5.5. Latin America

12.2.3.5.5.1. Market Estimation, 2015 – 2019

12.2.3.5.5.2. Market Forecast, 2020 – 2028

12.3. Key Segment for Channeling Investments

12.3.1. By Age Group

13. North America Anxiety and Depression Treatment Market Analysis and Forecasts, 2020 - 2028

13.1. Overview

13.1.1. North America Anxiety and Depression Treatment Market Revenue (US$ Mn)

13.2. North America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

13.2.1. Products

13.2.1.1. Benzodiazepine

13.2.1.2. Buspirone

13.2.1.3. Beta Blockers

13.2.1.3.1. Propranolol

13.2.1.3.2. Atenolol

13.2.1.3.3. Others

13.2.1.4. Others

13.2.2. Solutions

13.2.3. Services

13.2.3.1. Psychotherapy

13.2.3.1.1. Cognitive Behavioural Therapy (CBT)

13.2.3.1.2. Interpersonal Therapy (IPT)

13.2.3.1.3. Psychodynamic Therapy

13.2.3.1.4. Supportive Therapy

13.2.3.1.5. Others

13.2.3.2. Others

13.3. North America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

13.3.1. Short Term

13.3.2. Long Term

13.4. North America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

13.4.1. Anxiety

13.4.1.1. Panic Disorder

13.4.1.2. Social Anxiety Disorder

13.4.1.3. Obsessive Compulsive Disorder

13.4.1.4. Generalized Anxiety Disorder

13.4.1.5. Others

13.4.2. Depression

13.4.2.1. Major Depression

13.4.2.2. Persistent Depressive Disorder

13.4.2.3. Bipolar Disorder

13.4.2.4. Others

13.5. North America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.5.1. Online

13.5.2. Offline

13.5.2.1. Hospitals/Clinics

13.5.2.2. Wellness Centers

13.5.2.3. Research Centers

13.5.2.4. Others

13.6. North America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

13.6.1. Children

13.6.2. Adults

13.6.3. Senior Citizens

13.7. North America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Country

13.7.1. U.S

13.7.1.1. U.S Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

13.7.1.1.1. Products

13.7.1.1.1.1. Benzodiazepine

13.7.1.1.1.2. Buspirone

13.7.1.1.1.3. Beta Blockers

13.7.1.1.1.3.1. Propranolol

13.7.1.1.1.3.2. Atenolol

13.7.1.1.1.3.3. Others

13.7.1.1.1.4. Others

13.7.1.1.2. Solutions

13.7.1.1.3. Services

13.7.1.1.3.1. Psychotherapy

13.7.1.1.3.1.1. Cognitive Behavioural Therapy (CBT)

13.7.1.1.3.1.2. Interpersonal Therapy (IPT)

13.7.1.1.3.1.3. Psychodynamic Therapy

13.7.1.1.3.1.4. Supportive Therapy

13.7.1.1.3.1.5. Others

13.7.1.1.3.2. Others

13.7.1.2. U.S Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

13.7.1.2.1. Short Term

13.7.1.2.2. Long Term

13.7.1.3. U.S Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

13.7.1.3.1. Anxiety

13.7.1.3.1.1. Panic Disorder

13.7.1.3.1.2. Social Anxiety Disorder

13.7.1.3.1.3. Obsessive Compulsive Disorder

13.7.1.3.1.4. Generalized Anxiety Disorder

13.7.1.3.1.5. Others

13.7.1.3.2. Depression

13.7.1.3.2.1. Major Depression

13.7.1.3.2.2. Persistent Depressive Disorder

13.7.1.3.2.3. Bipolar Disorder

13.7.1.3.2.4. Others

13.7.1.4. U.S Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.7.1.4.1. Online

13.7.1.4.2. Offline

13.7.1.4.2.1. Hospitals/Clinics

13.7.1.4.2.2. Wellness Centers

13.7.1.4.2.3. Research Centers

13.7.1.4.2.4. Others

13.7.1.5. U.S Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

13.7.1.5.1. Children

13.7.1.5.2. Adults

13.7.1.5.3. Senior Citizens

13.7.2. Canada

13.7.2.1. Canada Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

13.7.2.1.1. Products

13.7.2.1.1.1. Benzodiazepine

13.7.2.1.1.2. Buspirone

13.7.2.1.1.3. Beta Blockers

13.7.2.1.1.3.1. Propranolol

13.7.2.1.1.3.2. Atenolol

13.7.2.1.1.3.3. Others

13.7.2.1.1.4. Others

13.7.2.1.2. Solutions

13.7.2.1.3. Services

13.7.2.1.3.1. Psychotherapy

13.7.2.1.3.1.1. Cognitive Behavioural Therapy (CBT)

13.7.2.1.3.1.2. Interpersonal Therapy (IPT)

13.7.2.1.3.1.3. Psychodynamic Therapy

13.7.2.1.3.1.4. Supportive Therapy

13.7.2.1.3.1.5. Others

13.7.2.1.3.2. Others

13.7.2.2. Canada Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

13.7.2.2.1. Short Term

13.7.2.2.2. Long Term

13.7.2.3. Canada Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

13.7.2.3.1. Anxiety

13.7.2.3.1.1. Panic Disorder

13.7.2.3.1.2. Social Anxiety Disorder

13.7.2.3.1.3. Obsessive Compulsive Disorder

13.7.2.3.1.4. Generalized Anxiety Disorder

13.7.2.3.1.5. Others

13.7.2.3.2. Depression

13.7.2.3.2.1. Major Depression

13.7.2.3.2.2. Persistent Depressive Disorder

13.7.2.3.2.3. Bipolar Disorder

13.7.2.3.2.4. Others

13.7.2.4. Canada Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.7.2.4.1. Online

13.7.2.4.2. Offline

13.7.2.4.2.1. Hospitals/Clinics

13.7.2.4.2.2. Wellness Centers

13.7.2.4.2.3. Research Centers

13.7.2.4.2.4. Others

13.7.2.5. Canada Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

13.7.2.5.1. Children

13.7.2.5.2. Adults

13.7.2.5.3. Senior Citizens

13.7.3. Mexico

13.7.3.1. Mexico Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

13.7.3.1.1. Products

13.7.3.1.1.1. Benzodiazepine

13.7.3.1.1.2. Buspirone

13.7.3.1.1.3. Beta Blockers

13.7.3.1.1.3.1. Propranolol

13.7.3.1.1.3.2. Atenolol

13.7.3.1.1.3.3. Others

13.7.3.1.1.4. Others

13.7.3.1.2. Solutions

13.7.3.1.3. Services

13.7.3.1.3.1. Psychotherapy

13.7.3.1.3.1.1. Cognitive Behavioural Therapy (CBT)

13.7.3.1.3.1.2. Interpersonal Therapy (IPT)

13.7.3.1.3.1.3. Psychodynamic Therapy

13.7.3.1.3.1.4. Supportive Therapy

13.7.3.1.3.1.5. Others

13.7.3.1.3.2. Others

13.7.3.2. Mexico Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

13.7.3.2.1. Short Term

13.7.3.2.2. Long Term

13.7.3.3. Mexico Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

13.7.3.3.1. Anxiety

13.7.3.3.1.1. Panic Disorder

13.7.3.3.1.2. Social Anxiety Disorder

13.7.3.3.1.3. Obsessive Compulsive Disorder

13.7.3.3.1.4. Generalized Anxiety Disorder

13.7.3.3.1.5. Others

13.7.3.3.2. Depression

13.7.3.3.2.1. Major Depression

13.7.3.3.2.2. Persistent Depressive Disorder

13.7.3.3.2.3. Bipolar Disorder

13.7.3.3.2.4. Others

13.7.3.4. Mexico Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.7.3.4.1. Online

13.7.3.4.2. Offline

13.7.3.4.2.1. Hospitals/Clinics

13.7.3.4.2.2. Wellness Centers

13.7.3.4.2.3. Research Centers

13.7.3.4.2.4. Others

13.7.3.5. Mexico Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

13.7.3.5.1. Children

13.7.3.5.2. Adults

13.7.3.5.3. Senior Citizens

13.7.4. Rest of North America

13.7.4.1. Rest of North America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

13.7.4.1.1. Products

13.7.4.1.1.1. Benzodiazepine

13.7.4.1.1.2. Buspirone

13.7.4.1.1.3. Beta Blockers

13.7.4.1.1.3.1. Propranolol

13.7.4.1.1.3.2. Atenolol

13.7.4.1.1.3.3. Others

13.7.4.1.1.4. Others

13.7.4.1.2. Solutions

13.7.4.1.3. Services

13.7.4.1.3.1. Psychotherapy

13.7.4.1.3.1.1. Cognitive Behavioural Therapy (CBT)

13.7.4.1.3.1.2. Interpersonal Therapy (IPT)

13.7.4.1.3.1.3. Psychodynamic Therapy

13.7.4.1.3.1.4. Supportive Therapy

13.7.4.1.3.1.5. Others

13.7.4.1.3.2. Others

13.7.4.2. Rest of North America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

13.7.4.2.1. Short Term

13.7.4.2.2. Long Term

13.7.4.3. Rest of North America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

13.7.4.3.1. Anxiety

13.7.4.3.1.1. Panic Disorder

13.7.4.3.1.2. Social Anxiety Disorder

13.7.4.3.1.3. Obsessive Compulsive Disorder

13.7.4.3.1.4. Generalized Anxiety Disorder

13.7.4.3.1.5. Others

13.7.4.3.2. Depression

13.7.4.3.2.1. Major Depression

13.7.4.3.2.2. Persistent Depressive Disorder

13.7.4.3.2.3. Bipolar Disorder

13.7.4.3.2.4. Others

13.7.4.4. Rest of North America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.7.4.4.1. Online

13.7.4.4.2. Offline

13.7.4.4.2.1. Hospitals/Clinics

13.7.4.4.2.2. Wellness Centers

13.7.4.4.2.3. Research Centers

13.7.4.4.2.4. Others

13.7.4.5. Rest of North America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

13.7.4.5.1. Children

13.7.4.5.2. Adults

13.7.4.5.3. Senior Citizens

13.8. Key Segment for Channeling Investments

13.8.1. By Country

13.8.2. By Offerings

13.8.3. By Treatment Duration

13.8.4. By Form

13.8.5. By Distribution Channel

13.8.6. By Age Group

14. Europe Anxiety and Depression Treatment Market Analysis and Forecasts, 2020 - 2028

14.1. Overview

14.1.1. Europe Anxiety and Depression Treatment Market Revenue (US$ Mn)

14.2. Europe Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

14.2.1. Products

14.2.1.1. Benzodiazepine

14.2.1.2. Buspirone

14.2.1.3. Beta Blockers

14.2.1.3.1. Propranolol

14.2.1.3.2. Atenolol

14.2.1.3.3. Others

14.2.1.4. Others

14.2.2. Solutions

14.2.3. Services

14.2.3.1. Psychotherapy

14.2.3.1.1. Cognitive Behavioural Therapy (CBT)

14.2.3.1.2. Interpersonal Therapy (IPT)

14.2.3.1.3. Psychodynamic Therapy

14.2.3.1.4. Supportive Therapy

14.2.3.1.5. Others

14.2.3.2. Others

14.3. Europe Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

14.3.1. Short Term

14.3.2. Long Term

14.4. Europe Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

14.4.1. Anxiety

14.4.1.1. Panic Disorder

14.4.1.2. Social Anxiety Disorder

14.4.1.3. Obsessive Compulsive Disorder

14.4.1.4. Generalized Anxiety Disorder

14.4.1.5. Others

14.4.2. Depression

14.4.2.1. Major Depression

14.4.2.2. Persistent Depressive Disorder

14.4.2.3. Bipolar Disorder

14.4.2.4. Others

14.5. Europe Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.5.1. Online

14.5.2. Offline

14.5.2.1. Hospitals/Clinics

14.5.2.2. Wellness Centers

14.5.2.3. Research Centers

14.5.2.4. Others

14.6. Europe Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

14.6.1. Children

14.6.2. Adults

14.6.3. Senior Citizens

14.7. Europe Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Country

14.7.1. France

14.7.1.1. France Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

14.7.1.1.1. Products

14.7.1.1.1.1. Benzodiazepine

14.7.1.1.1.2. Buspirone

14.7.1.1.1.3. Beta Blockers

14.7.1.1.1.3.1. Propranolol

14.7.1.1.1.3.2. Atenolol

14.7.1.1.1.3.3. Others

14.7.1.1.1.4. Others

14.7.1.1.2. Solutions

14.7.1.1.3. Services

14.7.1.1.3.1. Psychotherapy

14.7.1.1.3.1.1. Cognitive Behavioural Therapy (CBT)

14.7.1.1.3.1.2. Interpersonal Therapy (IPT)

14.7.1.1.3.1.3. Psychodynamic Therapy

14.7.1.1.3.1.4. Supportive Therapy

14.7.1.1.3.1.5. Others

14.7.1.1.3.2. Others

14.7.1.2. France Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

14.7.1.2.1. Short Term

14.7.1.2.2. Long Term

14.7.1.3. France Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

14.7.1.3.1. Anxiety

14.7.1.3.1.1. Panic Disorder

14.7.1.3.1.2. Social Anxiety Disorder

14.7.1.3.1.3. Obsessive Compulsive Disorder

14.7.1.3.1.4. Generalized Anxiety Disorder

14.7.1.3.1.5. Others

14.7.1.3.2. Depression

14.7.1.3.2.1. Major Depression

14.7.1.3.2.2. Persistent Depressive Disorder

14.7.1.3.2.3. Bipolar Disorder

14.7.1.3.2.4. Others

14.7.1.4. France Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.7.1.4.1. Online

14.7.1.4.2. Offline

14.7.1.4.2.1. Hospitals/Clinics

14.7.1.4.2.2. Wellness Centers

14.7.1.4.2.3. Research Centers

14.7.1.4.2.4. Others

14.7.1.5. France Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

14.7.1.5.1. Children

14.7.1.5.2. Adults

14.7.1.5.3. Senior Citizens

14.7.2. The UK

14.7.2.1. The UK Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

14.7.2.1.1. Products

14.7.2.1.1.1. Benzodiazepine

14.7.2.1.1.2. Buspirone

14.7.2.1.1.3. Beta Blockers

14.7.2.1.1.3.1. Propranolol

14.7.2.1.1.3.2. Atenolol

14.7.2.1.1.3.3. Others

14.7.2.1.1.4. Others

14.7.2.1.2. Solutions

14.7.2.1.3. Services

14.7.2.1.3.1. Psychotherapy

14.7.2.1.3.1.1. Cognitive Behavioural Therapy (CBT)

14.7.2.1.3.1.2. Interpersonal Therapy (IPT)

14.7.2.1.3.1.3. Psychodynamic Therapy

14.7.2.1.3.1.4. Supportive Therapy

14.7.2.1.3.1.5. Others

14.7.2.1.3.2. Others

14.7.2.2. The UK Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

14.7.2.2.1. Short Term

14.7.2.2.2. Long Term

14.7.2.3. The UK Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

14.7.2.3.1. Anxiety

14.7.2.3.1.1. Panic Disorder

14.7.2.3.1.2. Social Anxiety Disorder

14.7.2.3.1.3. Obsessive Compulsive Disorder

14.7.2.3.1.4. Generalized Anxiety Disorder

14.7.2.3.1.5. Others

14.7.2.3.2. Depression

14.7.2.3.2.1. Major Depression

14.7.2.3.2.2. Persistent Depressive Disorder

14.7.2.3.2.3. Bipolar Disorder

14.7.2.3.2.4. Others

14.7.2.4. The UK Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.7.2.4.1. Online

14.7.2.4.2. Offline

14.7.2.4.2.1. Hospitals/Clinics

14.7.2.4.2.2. Wellness Centers

14.7.2.4.2.3. Research Centers

14.7.2.4.2.4. Others

14.7.2.5. The UK Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

14.7.2.5.1. Children

14.7.2.5.2. Adults

14.7.2.5.3. Senior Citizens

14.7.3. Spain

14.7.3.1. Spain Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

14.7.3.1.1. Products

14.7.3.1.1.1. Benzodiazepine

14.7.3.1.1.2. Buspirone

14.7.3.1.1.3. Beta Blockers

14.7.3.1.1.3.1. Propranolol

14.7.3.1.1.3.2. Atenolol

14.7.3.1.1.3.3. Others

14.7.3.1.1.4. Others

14.7.3.1.2. Solutions

14.7.3.1.3. Services

14.7.3.1.3.1. Psychotherapy

14.7.3.1.3.1.1. Cognitive Behavioural Therapy (CBT)

14.7.3.1.3.1.2. Interpersonal Therapy (IPT)

14.7.3.1.3.1.3. Psychodynamic Therapy

14.7.3.1.3.1.4. Supportive Therapy

14.7.3.1.3.1.5. Others

14.7.3.1.3.2. Others

14.7.3.2. Spain Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

14.7.3.2.1. Short Term

14.7.3.2.2. Long Term

14.7.3.3. Spain Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

14.7.3.3.1. Anxiety

14.7.3.3.1.1. Panic Disorder

14.7.3.3.1.2. Social Anxiety Disorder

14.7.3.3.1.3. Obsessive Compulsive Disorder

14.7.3.3.1.4. Generalized Anxiety Disorder

14.7.3.3.1.5. Others

14.7.3.3.2. Depression

14.7.3.3.2.1. Major Depression

14.7.3.3.2.2. Persistent Depressive Disorder

14.7.3.3.2.3. Bipolar Disorder

14.7.3.3.2.4. Others

14.7.3.4. Spain Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.7.3.4.1. Online

14.7.3.4.2. Offline

14.7.3.4.2.1. Hospitals/Clinics

14.7.3.4.2.2. Wellness Centers

14.7.3.4.2.3. Research Centers

14.7.3.4.2.4. Others

14.7.3.5. Spain Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

14.7.3.5.1. Children

14.7.3.5.2. Adults

14.7.3.5.3. Senior Citizens

14.7.4. Germany

14.7.4.1. Germany Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

14.7.4.1.1. Products

14.7.4.1.1.1. Benzodiazepine

14.7.4.1.1.2. Buspirone

14.7.4.1.1.3. Beta Blockers

14.7.4.1.1.3.1. Propranolol

14.7.4.1.1.3.2. Atenolol

14.7.4.1.1.3.3. Others

14.7.4.1.1.4. Others

14.7.4.1.2. Solutions

14.7.4.1.3. Services

14.7.4.1.3.1. Psychotherapy

14.7.4.1.3.1.1. Cognitive Behavioural Therapy (CBT)

14.7.4.1.3.1.2. Interpersonal Therapy (IPT)

14.7.4.1.3.1.3. Psychodynamic Therapy

14.7.4.1.3.1.4. Supportive Therapy

14.7.4.1.3.1.5. Others

14.7.4.1.3.2. Others

14.7.4.2. Germany Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

14.7.4.2.1. Short Term

14.7.4.2.2. Long Term

14.7.4.3. Germany Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

14.7.4.3.1. Anxiety

14.7.4.3.1.1. Panic Disorder

14.7.4.3.1.2. Social Anxiety Disorder

14.7.4.3.1.3. Obsessive Compulsive Disorder

14.7.4.3.1.4. Generalized Anxiety Disorder

14.7.4.3.1.5. Others

14.7.4.3.2. Depression

14.7.4.3.2.1. Major Depression

14.7.4.3.2.2. Persistent Depressive Disorder

14.7.4.3.2.3. Bipolar Disorder

14.7.4.3.2.4. Others

14.7.4.4. Germany Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.7.4.4.1. Online

14.7.4.4.2. Offline

14.7.4.4.2.1. Hospitals/Clinics

14.7.4.4.2.2. Wellness Centers

14.7.4.4.2.3. Research Centers

14.7.4.4.2.4. Others

14.7.4.5. Germany Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

14.7.4.5.1. Children

14.7.4.5.2. Adults

14.7.4.5.3. Senior Citizens

14.7.5. Italy

14.7.5.1. Italy Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

14.7.5.1.1. Products

14.7.5.1.1.1. Benzodiazepine

14.7.5.1.1.2. Buspirone

14.7.5.1.1.3. Beta Blockers

14.7.5.1.1.3.1. Propranolol

14.7.5.1.1.3.2. Atenolol

14.7.5.1.1.3.3. Others

14.7.5.1.1.4. Others

14.7.5.1.2. Solutions

14.7.5.1.3. Services

14.7.5.1.3.1. Psychotherapy

14.7.5.1.3.1.1. Cognitive Behavioural Therapy (CBT)

14.7.5.1.3.1.2. Interpersonal Therapy (IPT)

14.7.5.1.3.1.3. Psychodynamic Therapy

14.7.5.1.3.1.4. Supportive Therapy

14.7.5.1.3.1.5. Others

14.7.5.1.3.2. Others

14.7.5.2. Italy Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

14.7.5.2.1. Short Term

14.7.5.2.2. Long Term

14.7.5.3. Italy Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

14.7.5.3.1. Anxiety

14.7.5.3.1.1. Panic Disorder

14.7.5.3.1.2. Social Anxiety Disorder

14.7.5.3.1.3. Obsessive Compulsive Disorder

14.7.5.3.1.4. Generalized Anxiety Disorder

14.7.5.3.1.5. Others

14.7.5.3.2. Depression

14.7.5.3.2.1. Major Depression

14.7.5.3.2.2. Persistent Depressive Disorder

14.7.5.3.2.3. Bipolar Disorder

14.7.5.3.2.4. Others

14.7.5.4. Italy Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.7.5.4.1. Online

14.7.5.4.2. Offline

14.7.5.4.2.1. Hospitals/Clinics

14.7.5.4.2.2. Wellness Centers

14.7.5.4.2.3. Research Centers

14.7.5.4.2.4. Others

14.7.5.5. Italy Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

14.7.5.5.1. Children

14.7.5.5.2. Adults

14.7.5.5.3. Senior Citizens

14.7.6. Nordic Countries

14.7.6.1. Nordic Countries Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

14.7.6.1.1. Products

14.7.6.1.1.1. Benzodiazepine

14.7.6.1.1.2. Buspirone

14.7.6.1.1.3. Beta Blockers

14.7.6.1.1.3.1. Propranolol

14.7.6.1.1.3.2. Atenolol

14.7.6.1.1.3.3. Others

14.7.6.1.1.4. Others

14.7.6.1.2. Solutions

14.7.6.1.3. Services

14.7.6.1.3.1. Psychotherapy

14.7.6.1.3.1.1. Cognitive Behavioural Therapy (CBT)

14.7.6.1.3.1.2. Interpersonal Therapy (IPT)

14.7.6.1.3.1.3. Psychodynamic Therapy

14.7.6.1.3.1.4. Supportive Therapy

14.7.6.1.3.1.5. Others

14.7.6.1.3.2. Others

14.7.6.2. Nordic Countries Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

14.7.6.2.1. Short Term

14.7.6.2.2. Long Term

14.7.6.3. Nordic Countries Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

14.7.6.3.1. Anxiety

14.7.6.3.1.1. Panic Disorder

14.7.6.3.1.2. Social Anxiety Disorder

14.7.6.3.1.3. Obsessive Compulsive Disorder

14.7.6.3.1.4. Generalized Anxiety Disorder

14.7.6.3.1.5. Others

14.7.6.3.2. Depression

14.7.6.3.2.1. Major Depression

14.7.6.3.2.2. Persistent Depressive Disorder

14.7.6.3.2.3. Bipolar Disorder

14.7.6.3.2.4. Others

14.7.6.4. Nordic Countries Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.7.6.4.1. Online

14.7.6.4.2. Offline

14.7.6.4.2.1. Hospitals/Clinics

14.7.6.4.2.2. Wellness Centers

14.7.6.4.2.3. Research Centers

14.7.6.4.2.4. Others

14.7.6.5. Nordic Countries Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

14.7.6.5.1. Children

14.7.6.5.2. Adults

14.7.6.5.3. Senior Citizens

14.7.6.6. Nordic Countries Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Country

14.7.6.6.1. Denmark

14.7.6.6.2. Finland

14.7.6.6.3. Iceland

14.7.6.6.4. Sweden

14.7.6.6.5. Norway

14.7.7. Benelux Union

14.7.7.1. Benelux Union Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

14.7.7.1.1. Products

14.7.7.1.1.1. Benzodiazepine

14.7.7.1.1.2. Buspirone

14.7.7.1.1.3. Beta Blockers

14.7.7.1.1.3.1. Propranolol

14.7.7.1.1.3.2. Atenolol

14.7.7.1.1.3.3. Others

14.7.7.1.1.4. Others

14.7.7.1.2. Solutions

14.7.7.1.3. Services

14.7.7.1.3.1. Psychotherapy

14.7.7.1.3.1.1. Cognitive Behavioural Therapy (CBT)

14.7.7.1.3.1.2. Interpersonal Therapy (IPT)

14.7.7.1.3.1.3. Psychodynamic Therapy

14.7.7.1.3.1.4. Supportive Therapy

14.7.7.1.3.1.5. Others

14.7.7.1.3.2. Others

14.7.7.2. Benelux Union Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

14.7.7.2.1. Short Term

14.7.7.2.2. Long Term

14.7.7.3. Benelux Union Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

14.7.7.3.1. Anxiety

14.7.7.3.1.1. Panic Disorder

14.7.7.3.1.2. Social Anxiety Disorder

14.7.7.3.1.3. Obsessive Compulsive Disorder

14.7.7.3.1.4. Generalized Anxiety Disorder

14.7.7.3.1.5. Others

14.7.7.3.2. Depression

14.7.7.3.2.1. Major Depression

14.7.7.3.2.2. Persistent Depressive Disorder

14.7.7.3.2.3. Bipolar Disorder

14.7.7.3.2.4. Others

14.7.7.4. Benelux Union Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.7.7.4.1. Online

14.7.7.4.2. Offline

14.7.7.4.2.1. Hospitals/Clinics

14.7.7.4.2.2. Wellness Centers

14.7.7.4.2.3. Research Centers

14.7.7.4.2.4. Others

14.7.7.5. Benelux Union Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

14.7.7.5.1. Children

14.7.7.5.2. Adults

14.7.7.5.3. Senior Citizens

14.7.7.6. Benelux Union Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Country

14.7.7.6.1. Belgium

14.7.7.6.2. The Netherlands

14.7.7.6.3. Luxembourg

14.7.8. Rest of Europe

14.7.8.1. Rest of Europe Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

14.7.8.1.1. Products

14.7.8.1.1.1. Benzodiazepine

14.7.8.1.1.2. Buspirone

14.7.8.1.1.3. Beta Blockers

14.7.8.1.1.3.1. Propranolol

14.7.8.1.1.3.2. Atenolol

14.7.8.1.1.3.3. Others

14.7.8.1.1.4. Others

14.7.8.1.2. Solutions

14.7.8.1.3. Services

14.7.8.1.3.1. Psychotherapy

14.7.8.1.3.1.1. Cognitive Behavioural Therapy (CBT)

14.7.8.1.3.1.2. Interpersonal Therapy (IPT)

14.7.8.1.3.1.3. Psychodynamic Therapy

14.7.8.1.3.1.4. Supportive Therapy

14.7.8.1.3.1.5. Others

14.7.8.1.3.2. Others

14.7.8.2. Rest of Europe Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

14.7.8.2.1. Short Term

14.7.8.2.2. Long Term

14.7.8.3. Rest of Europe Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

14.7.8.3.1. Anxiety

14.7.8.3.1.1. Panic Disorder

14.7.8.3.1.2. Social Anxiety Disorder

14.7.8.3.1.3. Obsessive Compulsive Disorder

14.7.8.3.1.4. Generalized Anxiety Disorder

14.7.8.3.1.5. Others

14.7.8.3.2. Depression

14.7.8.3.2.1. Major Depression

14.7.8.3.2.2. Persistent Depressive Disorder

14.7.8.3.2.3. Bipolar Disorder

14.7.8.3.2.4. Others

14.7.8.4. Rest of Europe Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.7.8.4.1. Online

14.7.8.4.2. Offline

14.7.8.4.2.1. Hospitals/Clinics

14.7.8.4.2.2. Wellness Centers

14.7.8.4.2.3. Research Centers

14.7.8.4.2.4. Others

14.7.8.5. Rest of Europe Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

14.7.8.5.1. Children

14.7.8.5.2. Adults

14.7.8.5.3. Senior Citizens

14.8. Key Segment for Channeling Investments

14.8.1. By Country

14.8.2. By Offerings

14.8.3. By Treatment Duration

14.8.4. By Form

14.8.5. By Distribution Channel

14.8.6. By Age Group

15. Asia Pacific Anxiety and Depression Treatment Market Analysis and Forecasts, 2020 - 2028

15.1. Overview

15.1.1. Asia Pacific Anxiety and Depression Treatment Market Revenue (US$ Mn)

15.2. Asia Pacific Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

15.2.1. Products

15.2.1.1. Benzodiazepine

15.2.1.2. Buspirone

15.2.1.3. Beta Blockers

15.2.1.3.1. Propranolol

15.2.1.3.2. Atenolol

15.2.1.3.3. Others

15.2.1.4. Others

15.2.2. Solutions

15.2.3. Services

15.2.3.1. Psychotherapy

15.2.3.1.1. Cognitive Behavioural Therapy (CBT)

15.2.3.1.2. Interpersonal Therapy (IPT)

15.2.3.1.3. Psychodynamic Therapy

15.2.3.1.4. Supportive Therapy

15.2.3.1.5. Others

15.2.3.2. Others

15.3. Asia Pacific Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

15.3.1. Short Term

15.3.2. Long Term

15.4. Asia Pacific Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

15.4.1. Anxiety

15.4.1.1. Panic Disorder

15.4.1.2. Social Anxiety Disorder

15.4.1.3. Obsessive Compulsive Disorder

15.4.1.4. Generalized Anxiety Disorder

15.4.1.5. Others

15.4.2. Depression

15.4.2.1. Major Depression

15.4.2.2. Persistent Depressive Disorder

15.4.2.3. Bipolar Disorder

15.4.2.4. Others

15.5. Asia Pacific Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.5.1. Online

15.5.2. Offline

15.5.2.1. Hospitals/Clinics

15.5.2.2. Wellness Centers

15.5.2.3. Research Centers

15.5.2.4. Others

15.6. Asia Pacific Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

15.6.1. Children

15.6.2. Adults

15.6.3. Senior Citizens

15.7. Asia Pacific Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Country

15.7.1. China

15.7.1.1. China Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

15.7.1.1.1. Products

15.7.1.1.1.1. Benzodiazepine

15.7.1.1.1.2. Buspirone

15.7.1.1.1.3. Beta Blockers

15.7.1.1.1.3.1. Propranolol

15.7.1.1.1.3.2. Atenolol

15.7.1.1.1.3.3. Others

15.7.1.1.1.4. Others

15.7.1.1.2. Solutions

15.7.1.1.3. Services

15.7.1.1.3.1. Psychotherapy

15.7.1.1.3.1.1. Cognitive Behavioural Therapy (CBT)

15.7.1.1.3.1.2. Interpersonal Therapy (IPT)

15.7.1.1.3.1.3. Psychodynamic Therapy

15.7.1.1.3.1.4. Supportive Therapy

15.7.1.1.3.1.5. Others

15.7.1.1.3.2. Others

15.7.1.2. China Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

15.7.1.2.1. Short Term

15.7.1.2.2. Long Term

15.7.1.3. China Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

15.7.1.3.1. Anxiety

15.7.1.3.1.1. Panic Disorder

15.7.1.3.1.2. Social Anxiety Disorder

15.7.1.3.1.3. Obsessive Compulsive Disorder

15.7.1.3.1.4. Generalized Anxiety Disorder

15.7.1.3.1.5. Others

15.7.1.3.2. Depression

15.7.1.3.2.1. Major Depression

15.7.1.3.2.2. Persistent Depressive Disorder

15.7.1.3.2.3. Bipolar Disorder

15.7.1.3.2.4. Others

15.7.1.4. China Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.7.1.4.1. Online

15.7.1.4.2. Offline

15.7.1.4.2.1. Hospitals/Clinics

15.7.1.4.2.2. Wellness Centers

15.7.1.4.2.3. Research Centers

15.7.1.4.2.4. Others

15.7.1.5. China Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

15.7.1.5.1. Children

15.7.1.5.2. Adults

15.7.1.5.3. Senior Citizens

15.7.2. Japan

15.7.2.1. Japan Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

15.7.2.1.1. Products

15.7.2.1.1.1. Benzodiazepine

15.7.2.1.1.2. Buspirone

15.7.2.1.1.3. Beta Blockers

15.7.2.1.1.3.1. Propranolol

15.7.2.1.1.3.2. Atenolol

15.7.2.1.1.3.3. Others

15.7.2.1.1.4. Others

15.7.2.1.2. Solutions

15.7.2.1.3. Services

15.7.2.1.3.1. Psychotherapy

15.7.2.1.3.1.1. Cognitive Behavioural Therapy (CBT)

15.7.2.1.3.1.2. Interpersonal Therapy (IPT)

15.7.2.1.3.1.3. Psychodynamic Therapy

15.7.2.1.3.1.4. Supportive Therapy

15.7.2.1.3.1.5. Others

15.7.2.1.3.2. Others

15.7.2.2. Japan Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

15.7.2.2.1. Short Term

15.7.2.2.2. Long Term

15.7.2.3. Japan Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

15.7.2.3.1. Anxiety

15.7.2.3.1.1. Panic Disorder

15.7.2.3.1.2. Social Anxiety Disorder

15.7.2.3.1.3. Obsessive Compulsive Disorder

15.7.2.3.1.4. Generalized Anxiety Disorder

15.7.2.3.1.5. Others

15.7.2.3.2. Depression

15.7.2.3.2.1. Major Depression

15.7.2.3.2.2. Persistent Depressive Disorder

15.7.2.3.2.3. Bipolar Disorder

15.7.2.3.2.4. Others

15.7.2.4. Japan Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.7.2.4.1. Online

15.7.2.4.2. Offline

15.7.2.4.2.1. Hospitals/Clinics

15.7.2.4.2.2. Wellness Centers

15.7.2.4.2.3. Research Centers

15.7.2.4.2.4. Others

15.7.2.5. Japan Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

15.7.2.5.1. Children

15.7.2.5.2. Adults

15.7.2.5.3. Senior Citizens

15.7.3. India

15.7.3.1. India Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

15.7.3.1.1. Products

15.7.3.1.1.1. Benzodiazepine

15.7.3.1.1.2. Buspirone

15.7.3.1.1.3. Beta Blockers

15.7.3.1.1.3.1. Propranolol

15.7.3.1.1.3.2. Atenolol

15.7.3.1.1.3.3. Others

15.7.3.1.1.4. Others

15.7.3.1.2. Solutions

15.7.3.1.3. Services

15.7.3.1.3.1. Psychotherapy

15.7.3.1.3.1.1. Cognitive Behavioural Therapy (CBT)

15.7.3.1.3.1.2. Interpersonal Therapy (IPT)

15.7.3.1.3.1.3. Psychodynamic Therapy

15.7.3.1.3.1.4. Supportive Therapy

15.7.3.1.3.1.5. Others

15.7.3.1.3.2. Others

15.7.3.2. India Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

15.7.3.2.1. Short Term

15.7.3.2.2. Long Term

15.7.3.3. India Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

15.7.3.3.1. Anxiety

15.7.3.3.1.1. Panic Disorder

15.7.3.3.1.2. Social Anxiety Disorder

15.7.3.3.1.3. Obsessive Compulsive Disorder

15.7.3.3.1.4. Generalized Anxiety Disorder

15.7.3.3.1.5. Others

15.7.3.3.2. Depression

15.7.3.3.2.1. Major Depression

15.7.3.3.2.2. Persistent Depressive Disorder

15.7.3.3.2.3. Bipolar Disorder

15.7.3.3.2.4. Others

15.7.3.4. India Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.7.3.4.1. Online

15.7.3.4.2. Offline

15.7.3.4.2.1. Hospitals/Clinics

15.7.3.4.2.2. Wellness Centers

15.7.3.4.2.3. Research Centers

15.7.3.4.2.4. Others

15.7.3.5. India Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

15.7.3.5.1. Children

15.7.3.5.2. Adults

15.7.3.5.3. Senior Citizens

15.7.4. New Zealand

15.7.4.1. New Zealand Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

15.7.4.1.1. Products

15.7.4.1.1.1. Benzodiazepine

15.7.4.1.1.2. Buspirone

15.7.4.1.1.3. Beta Blockers

15.7.4.1.1.3.1. Propranolol

15.7.4.1.1.3.2. Atenolol

15.7.4.1.1.3.3. Others

15.7.4.1.1.4. Others

15.7.4.1.2. Solutions

15.7.4.1.3. Services

15.7.4.1.3.1. Psychotherapy

15.7.4.1.3.1.1. Cognitive Behavioural Therapy (CBT)

15.7.4.1.3.1.2. Interpersonal Therapy (IPT)

15.7.4.1.3.1.3. Psychodynamic Therapy

15.7.4.1.3.1.4. Supportive Therapy

15.7.4.1.3.1.5. Others

15.7.4.1.3.2. Others

15.7.4.2. New Zealand Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

15.7.4.2.1. Short Term

15.7.4.2.2. Long Term

15.7.4.3. New Zealand Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

15.7.4.3.1. Anxiety

15.7.4.3.1.1. Panic Disorder

15.7.4.3.1.2. Social Anxiety Disorder

15.7.4.3.1.3. Obsessive Compulsive Disorder

15.7.4.3.1.4. Generalized Anxiety Disorder

15.7.4.3.1.5. Others

15.7.4.3.2. Depression

15.7.4.3.2.1. Major Depression

15.7.4.3.2.2. Persistent Depressive Disorder

15.7.4.3.2.3. Bipolar Disorder

15.7.4.3.2.4. Others

15.7.4.4. New Zealand Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.7.4.4.1. Online

15.7.4.4.2. Offline

15.7.4.4.2.1. Hospitals/Clinics

15.7.4.4.2.2. Wellness Centers

15.7.4.4.2.3. Research Centers

15.7.4.4.2.4. Others

15.7.4.5. New Zealand Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

15.7.4.5.1. Children

15.7.4.5.2. Adults

15.7.4.5.3. Senior Citizens

15.7.5. Australia

15.7.5.1. Australia Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

15.7.5.1.1. Products

15.7.5.1.1.1. Benzodiazepine

15.7.5.1.1.2. Buspirone

15.7.5.1.1.3. Beta Blockers

15.7.5.1.1.3.1. Propranolol

15.7.5.1.1.3.2. Atenolol

15.7.5.1.1.3.3. Others

15.7.5.1.1.4. Others

15.7.5.1.2. Solutions

15.7.5.1.3. Services

15.7.5.1.3.1. Psychotherapy

15.7.5.1.3.1.1. Cognitive Behavioural Therapy (CBT)

15.7.5.1.3.1.2. Interpersonal Therapy (IPT)

15.7.5.1.3.1.3. Psychodynamic Therapy

15.7.5.1.3.1.4. Supportive Therapy

15.7.5.1.3.1.5. Others

15.7.5.1.3.2. Others

15.7.5.2. Australia Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

15.7.5.2.1. Short Term

15.7.5.2.2. Long Term

15.7.5.3. Australia Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

15.7.5.3.1. Anxiety

15.7.5.3.1.1. Panic Disorder

15.7.5.3.1.2. Social Anxiety Disorder

15.7.5.3.1.3. Obsessive Compulsive Disorder

15.7.5.3.1.4. Generalized Anxiety Disorder

15.7.5.3.1.5. Others

15.7.5.3.2. Depression

15.7.5.3.2.1. Major Depression

15.7.5.3.2.2. Persistent Depressive Disorder

15.7.5.3.2.3. Bipolar Disorder

15.7.5.3.2.4. Others

15.7.5.4. Australia Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.7.5.4.1. Online

15.7.5.4.2. Offline

15.7.5.4.2.1. Hospitals/Clinics

15.7.5.4.2.2. Wellness Centers

15.7.5.4.2.3. Research Centers

15.7.5.4.2.4. Others

15.7.5.5. Australia Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

15.7.5.5.1. Children

15.7.5.5.2. Adults

15.7.5.5.3. Senior Citizens

15.7.6. South Korea

15.7.6.1. South Korea Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

15.7.6.1.1. Products

15.7.6.1.1.1. Benzodiazepine

15.7.6.1.1.2. Buspirone

15.7.6.1.1.3. Beta Blockers

15.7.6.1.1.3.1. Propranolol

15.7.6.1.1.3.2. Atenolol

15.7.6.1.1.3.3. Others

15.7.6.1.1.4. Others

15.7.6.1.2. Solutions

15.7.6.1.3. Services

15.7.6.1.3.1. Psychotherapy

15.7.6.1.3.1.1. Cognitive Behavioural Therapy (CBT)

15.7.6.1.3.1.2. Interpersonal Therapy (IPT)

15.7.6.1.3.1.3. Psychodynamic Therapy

15.7.6.1.3.1.4. Supportive Therapy

15.7.6.1.3.1.5. Others

15.7.6.1.3.2. Others

15.7.6.2. South Korea Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

15.7.6.2.1. Short Term

15.7.6.2.2. Long Term

15.7.6.3. South Korea Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

15.7.6.3.1. Anxiety

15.7.6.3.1.1. Panic Disorder

15.7.6.3.1.2. Social Anxiety Disorder

15.7.6.3.1.3. Obsessive Compulsive Disorder

15.7.6.3.1.4. Generalized Anxiety Disorder

15.7.6.3.1.5. Others

15.7.6.3.2. Depression

15.7.6.3.2.1. Major Depression

15.7.6.3.2.2. Persistent Depressive Disorder

15.7.6.3.2.3. Bipolar Disorder

15.7.6.3.2.4. Others

15.7.6.4. South Korea Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.7.6.4.1. Online

15.7.6.4.2. Offline

15.7.6.4.2.1. Hospitals/Clinics

15.7.6.4.2.2. Wellness Centers

15.7.6.4.2.3. Research Centers

15.7.6.4.2.4. Others

15.7.6.5. South Korea Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

15.7.6.5.1. Children

15.7.6.5.2. Adults

15.7.6.5.3. Senior Citizens

15.7.7. Southeast Asia

15.7.7.1. Southeast Asia Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

15.7.7.1.1. Products

15.7.7.1.1.1. Benzodiazepine

15.7.7.1.1.2. Buspirone

15.7.7.1.1.3. Beta Blockers

15.7.7.1.1.3.1. Propranolol

15.7.7.1.1.3.2. Atenolol

15.7.7.1.1.3.3. Others

15.7.7.1.1.4. Others

15.7.7.1.2. Solutions

15.7.7.1.3. Services

15.7.7.1.3.1. Psychotherapy

15.7.7.1.3.1.1. Cognitive Behavioural Therapy (CBT)

15.7.7.1.3.1.2. Interpersonal Therapy (IPT)

15.7.7.1.3.1.3. Psychodynamic Therapy

15.7.7.1.3.1.4. Supportive Therapy

15.7.7.1.3.1.5. Others

15.7.7.1.3.2. Others

15.7.7.2. Southeast Asia Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

15.7.7.2.1. Short Term

15.7.7.2.2. Long Term

15.7.7.3. Southeast Asia Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

15.7.7.3.1. Anxiety

15.7.7.3.1.1. Panic Disorder

15.7.7.3.1.2. Social Anxiety Disorder

15.7.7.3.1.3. Obsessive Compulsive Disorder

15.7.7.3.1.4. Generalized Anxiety Disorder

15.7.7.3.1.5. Others

15.7.7.3.2. Depression

15.7.7.3.2.1. Major Depression

15.7.7.3.2.2. Persistent Depressive Disorder

15.7.7.3.2.3. Bipolar Disorder

15.7.7.3.2.4. Others

15.7.7.4. Southeast Asia Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.7.7.4.1. Online

15.7.7.4.2. Offline

15.7.7.4.2.1. Hospitals/Clinics

15.7.7.4.2.2. Wellness Centers

15.7.7.4.2.3. Research Centers

15.7.7.4.2.4. Others

15.7.7.5. Southeast Asia Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

15.7.7.5.1. Children

15.7.7.5.2. Adults

15.7.7.5.3. Senior Citizens

15.7.7.6. Southeast Asia Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Country

15.7.7.6.1. Indonesia

15.7.7.6.2. Thailand

15.7.7.6.3. Malaysia

15.7.7.6.4. Singapore

15.7.7.6.5. Rest of Southeast Asia

15.7.8. Rest of Asia Pacific

15.7.8.1. Rest of Asia Pacific Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

15.7.8.1.1. Products

15.7.8.1.1.1. Benzodiazepine

15.7.8.1.1.2. Buspirone

15.7.8.1.1.3. Beta Blockers

15.7.8.1.1.3.1. Propranolol

15.7.8.1.1.3.2. Atenolol

15.7.8.1.1.3.3. Others

15.7.8.1.1.4. Others

15.7.8.1.2. Solutions

15.7.8.1.3. Services

15.7.8.1.3.1. Psychotherapy

15.7.8.1.3.1.1. Cognitive Behavioural Therapy (CBT)

15.7.8.1.3.1.2. Interpersonal Therapy (IPT)

15.7.8.1.3.1.3. Psychodynamic Therapy

15.7.8.1.3.1.4. Supportive Therapy

15.7.8.1.3.1.5. Others

15.7.8.1.3.2. Others

15.7.8.2. Rest of Asia Pacific Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

15.7.8.2.1. Short Term

15.7.8.2.2. Long Term

15.7.8.3. Rest of Asia Pacific Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

15.7.8.3.1. Anxiety

15.7.8.3.1.1. Panic Disorder

15.7.8.3.1.2. Social Anxiety Disorder

15.7.8.3.1.3. Obsessive Compulsive Disorder

15.7.8.3.1.4. Generalized Anxiety Disorder

15.7.8.3.1.5. Others

15.7.8.3.2. Depression

15.7.8.3.2.1. Major Depression

15.7.8.3.2.2. Persistent Depressive Disorder

15.7.8.3.2.3. Bipolar Disorder

15.7.8.3.2.4. Others

15.7.8.4. Rest of Asia Pacific Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.7.8.4.1. Online

15.7.8.4.2. Offline

15.7.8.4.2.1. Hospitals/Clinics

15.7.8.4.2.2. Wellness Centers

15.7.8.4.2.3. Research Centers

15.7.8.4.2.4. Others

15.7.8.5. Rest of Asia Pacific Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

15.7.8.5.1. Children

15.7.8.5.2. Adults

15.7.8.5.3. Senior Citizens

15.8. Key Segment for Channeling Investments

15.8.1. By Country

15.8.2. By Offerings

15.8.3. By Treatment Duration

15.8.4. By Form

15.8.5. By Distribution Channel

15.8.6. By Age Group

16. Middle East and Africa Anxiety and Depression Treatment Market Analysis and Forecasts, 2020 - 2028

16.1. Overview

16.1.1. Middle East and Africa Anxiety and Depression Treatment Market Revenue (US$ Mn)

16.2. Middle East and Africa Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

16.2.1. Products

16.2.1.1. Benzodiazepine

16.2.1.2. Buspirone

16.2.1.3. Beta Blockers

16.2.1.3.1. Propranolol

16.2.1.3.2. Atenolol

16.2.1.3.3. Others

16.2.1.4. Others

16.2.2. Solutions

16.2.3. Services

16.2.3.1. Psychotherapy

16.2.3.1.1. Cognitive Behavioural Therapy (CBT)

16.2.3.1.2. Interpersonal Therapy (IPT)

16.2.3.1.3. Psychodynamic Therapy

16.2.3.1.4. Supportive Therapy

16.2.3.1.5. Others

16.2.3.2. Others

16.3. Middle East and Africa Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

16.3.1. Short Term

16.3.2. Long Term

16.4. Middle East and Africa Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

16.4.1. Anxiety

16.4.1.1. Panic Disorder

16.4.1.2. Social Anxiety Disorder

16.4.1.3. Obsessive Compulsive Disorder

16.4.1.4. Generalized Anxiety Disorder

16.4.1.5. Others

16.4.2. Depression

16.4.2.1. Major Depression

16.4.2.2. Persistent Depressive Disorder

16.4.2.3. Bipolar Disorder

16.4.2.4. Others

16.5. Middle East and Africa Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.5.1. Online

16.5.2. Offline

16.5.2.1. Hospitals/Clinics

16.5.2.2. Wellness Centers

16.5.2.3. Research Centers

16.5.2.4. Others

16.6. Middle East and Africa Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

16.6.1. Children

16.6.2. Adults

16.6.3. Senior Citizens

16.7. Middle East and Africa Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Country

16.7.1. Saudi Arabia

16.7.1.1. Saudi Arabia Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

16.7.1.1.1. Products

16.7.1.1.1.1. Benzodiazepine

16.7.1.1.1.2. Buspirone

16.7.1.1.1.3. Beta Blockers

16.7.1.1.1.3.1. Propranolol

16.7.1.1.1.3.2. Atenolol

16.7.1.1.1.3.3. Others

16.7.1.1.1.4. Others

16.7.1.1.2. Solutions

16.7.1.1.3. Services

16.7.1.1.3.1. Psychotherapy

16.7.1.1.3.1.1. Cognitive Behavioural Therapy (CBT)

16.7.1.1.3.1.2. Interpersonal Therapy (IPT)

16.7.1.1.3.1.3. Psychodynamic Therapy

16.7.1.1.3.1.4. Supportive Therapy

16.7.1.1.3.1.5. Others

16.7.1.1.3.2. Others

16.7.1.2. Saudi Arabia Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

16.7.1.2.1. Short Term

16.7.1.2.2. Long Term

16.7.1.3. Saudi Arabia Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

16.7.1.3.1. Anxiety

16.7.1.3.1.1. Panic Disorder

16.7.1.3.1.2. Social Anxiety Disorder

16.7.1.3.1.3. Obsessive Compulsive Disorder

16.7.1.3.1.4. Generalized Anxiety Disorder

16.7.1.3.1.5. Others

16.7.1.3.2. Depression

16.7.1.3.2.1. Major Depression

16.7.1.3.2.2. Persistent Depressive Disorder

16.7.1.3.2.3. Bipolar Disorder

16.7.1.3.2.4. Others

16.7.1.4. Saudi Arabia Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.7.1.4.1. Online

16.7.1.4.2. Offline

16.7.1.4.2.1. Hospitals/Clinics

16.7.1.4.2.2. Wellness Centers

16.7.1.4.2.3. Research Centers

16.7.1.4.2.4. Others

16.7.1.5. Saudi Arabia Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

16.7.1.5.1. Children

16.7.1.5.2. Adults

16.7.1.5.3. Senior Citizens

16.7.2. UAE

16.7.2.1. UAE Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

16.7.2.1.1. Products

16.7.2.1.1.1. Benzodiazepine

16.7.2.1.1.2. Buspirone

16.7.2.1.1.3. Beta Blockers

16.7.2.1.1.3.1. Propranolol

16.7.2.1.1.3.2. Atenolol

16.7.2.1.1.3.3. Others

16.7.2.1.1.4. Others

16.7.2.1.2. Solutions

16.7.2.1.3. Services

16.7.2.1.3.1. Psychotherapy

16.7.2.1.3.1.1. Cognitive Behavioural Therapy (CBT)

16.7.2.1.3.1.2. Interpersonal Therapy (IPT)

16.7.2.1.3.1.3. Psychodynamic Therapy

16.7.2.1.3.1.4. Supportive Therapy

16.7.2.1.3.1.5. Others

16.7.2.1.3.2. Others

16.7.2.2. UAE Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

16.7.2.2.1. Short Term

16.7.2.2.2. Long Term

16.7.2.3. UAE Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

16.7.2.3.1. Anxiety

16.7.2.3.1.1. Panic Disorder

16.7.2.3.1.2. Social Anxiety Disorder

16.7.2.3.1.3. Obsessive Compulsive Disorder

16.7.2.3.1.4. Generalized Anxiety Disorder

16.7.2.3.1.5. Others

16.7.2.3.2. Depression

16.7.2.3.2.1. Major Depression

16.7.2.3.2.2. Persistent Depressive Disorder

16.7.2.3.2.3. Bipolar Disorder

16.7.2.3.2.4. Others

16.7.2.4. UAE Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.7.2.4.1. Online

16.7.2.4.2. Offline

16.7.2.4.2.1. Hospitals/Clinics

16.7.2.4.2.2. Wellness Centers

16.7.2.4.2.3. Research Centers

16.7.2.4.2.4. Others

16.7.2.5. UAE Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

16.7.2.5.1. Children

16.7.2.5.2. Adults

16.7.2.5.3. Senior Citizens

16.7.3. Egypt

16.7.3.1. Egypt Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

16.7.3.1.1. Products

16.7.3.1.1.1. Benzodiazepine

16.7.3.1.1.2. Buspirone

16.7.3.1.1.3. Beta Blockers

16.7.3.1.1.3.1. Propranolol

16.7.3.1.1.3.2. Atenolol

16.7.3.1.1.3.3. Others

16.7.3.1.1.4. Others

16.7.3.1.2. Solutions

16.7.3.1.3. Services

16.7.3.1.3.1. Psychotherapy

16.7.3.1.3.1.1. Cognitive Behavioural Therapy (CBT)

16.7.3.1.3.1.2. Interpersonal Therapy (IPT)

16.7.3.1.3.1.3. Psychodynamic Therapy

16.7.3.1.3.1.4. Supportive Therapy

16.7.3.1.3.1.5. Others

16.7.3.1.3.2. Others

16.7.3.2. Egypt Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

16.7.3.2.1. Short Term

16.7.3.2.2. Long Term

16.7.3.3. Egypt Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

16.7.3.3.1. Anxiety

16.7.3.3.1.1. Panic Disorder

16.7.3.3.1.2. Social Anxiety Disorder

16.7.3.3.1.3. Obsessive Compulsive Disorder

16.7.3.3.1.4. Generalized Anxiety Disorder

16.7.3.3.1.5. Others

16.7.3.3.2. Depression

16.7.3.3.2.1. Major Depression

16.7.3.3.2.2. Persistent Depressive Disorder

16.7.3.3.2.3. Bipolar Disorder

16.7.3.3.2.4. Others

16.7.3.4. Egypt Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.7.3.4.1. Online

16.7.3.4.2. Offline

16.7.3.4.2.1. Hospitals/Clinics

16.7.3.4.2.2. Wellness Centers

16.7.3.4.2.3. Research Centers

16.7.3.4.2.4. Others

16.7.3.5. Egypt Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

16.7.3.5.1. Children

16.7.3.5.2. Adults

16.7.3.5.3. Senior Citizens

16.7.4. Kuwait

16.7.4.1. Kuwait Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

16.7.4.1.1. Products

16.7.4.1.1.1. Benzodiazepine

16.7.4.1.1.2. Buspirone

16.7.4.1.1.3. Beta Blockers

16.7.4.1.1.3.1. Propranolol

16.7.4.1.1.3.2. Atenolol

16.7.4.1.1.3.3. Others

16.7.4.1.1.4. Others

16.7.4.1.2. Solutions

16.7.4.1.3. Services

16.7.4.1.3.1. Psychotherapy

16.7.4.1.3.1.1. Cognitive Behavioural Therapy (CBT)

16.7.4.1.3.1.2. Interpersonal Therapy (IPT)

16.7.4.1.3.1.3. Psychodynamic Therapy

16.7.4.1.3.1.4. Supportive Therapy

16.7.4.1.3.1.5. Others

16.7.4.1.3.2. Others

16.7.4.2. Kuwait Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

16.7.4.2.1. Short Term

16.7.4.2.2. Long Term

16.7.4.3. Kuwait Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

16.7.4.3.1. Anxiety

16.7.4.3.1.1. Panic Disorder

16.7.4.3.1.2. Social Anxiety Disorder

16.7.4.3.1.3. Obsessive Compulsive Disorder

16.7.4.3.1.4. Generalized Anxiety Disorder

16.7.4.3.1.5. Others

16.7.4.3.2. Depression

16.7.4.3.2.1. Major Depression

16.7.4.3.2.2. Persistent Depressive Disorder

16.7.4.3.2.3. Bipolar Disorder

16.7.4.3.2.4. Others

16.7.4.4. Kuwait Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.7.4.4.1. Online

16.7.4.4.2. Offline

16.7.4.4.2.1. Hospitals/Clinics

16.7.4.4.2.2. Wellness Centers

16.7.4.4.2.3. Research Centers

16.7.4.4.2.4. Others

16.7.4.5. Kuwait Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

16.7.4.5.1. Children

16.7.4.5.2. Adults

16.7.4.5.3. Senior Citizens

16.7.5. South Africa

16.7.5.1. South Africa Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

16.7.5.1.1. Products

16.7.5.1.1.1. Benzodiazepine

16.7.5.1.1.2. Buspirone

16.7.5.1.1.3. Beta Blockers

16.7.5.1.1.3.1. Propranolol

16.7.5.1.1.3.2. Atenolol

16.7.5.1.1.3.3. Others

16.7.5.1.1.4. Others

16.7.5.1.2. Solutions

16.7.5.1.3. Services

16.7.5.1.3.1. Psychotherapy

16.7.5.1.3.1.1. Cognitive Behavioural Therapy (CBT)

16.7.5.1.3.1.2. Interpersonal Therapy (IPT)

16.7.5.1.3.1.3. Psychodynamic Therapy

16.7.5.1.3.1.4. Supportive Therapy

16.7.5.1.3.1.5. Others

16.7.5.1.3.2. Others

16.7.5.2. South Africa Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

16.7.5.2.1. Short Term

16.7.5.2.2. Long Term

16.7.5.3. South Africa Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

16.7.5.3.1. Anxiety

16.7.5.3.1.1. Panic Disorder

16.7.5.3.1.2. Social Anxiety Disorder

16.7.5.3.1.3. Obsessive Compulsive Disorder

16.7.5.3.1.4. Generalized Anxiety Disorder

16.7.5.3.1.5. Others

16.7.5.3.2. Depression

16.7.5.3.2.1. Major Depression

16.7.5.3.2.2. Persistent Depressive Disorder

16.7.5.3.2.3. Bipolar Disorder

16.7.5.3.2.4. Others

16.7.5.4. South Africa Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.7.5.4.1. Online

16.7.5.4.2. Offline

16.7.5.4.2.1. Hospitals/Clinics

16.7.5.4.2.2. Wellness Centers

16.7.5.4.2.3. Research Centers

16.7.5.4.2.4. Others

16.7.5.5. South Africa Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

16.7.5.5.1. Children

16.7.5.5.2. Adults

16.7.5.5.3. Senior Citizens

16.7.6. Rest of Middle East & Africa

16.7.6.1. Rest of Middle East & Africa Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

16.7.6.1.1. Products

16.7.6.1.1.1. Benzodiazepine

16.7.6.1.1.2. Buspirone

16.7.6.1.1.3. Beta Blockers

16.7.6.1.1.3.1. Propranolol

16.7.6.1.1.3.2. Atenolol

16.7.6.1.1.3.3. Others

16.7.6.1.1.4. Others

16.7.6.1.2. Solutions

16.7.6.1.3. Services

16.7.6.1.3.1. Psychotherapy

16.7.6.1.3.1.1. Cognitive Behavioural Therapy (CBT)

16.7.6.1.3.1.2. Interpersonal Therapy (IPT)

16.7.6.1.3.1.3. Psychodynamic Therapy

16.7.6.1.3.1.4. Supportive Therapy

16.7.6.1.3.1.5. Others

16.7.6.1.3.2. Others

16.7.6.2. Rest of Middle East & Africa Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

16.7.6.2.1. Short Term

16.7.6.2.2. Long Term

16.7.6.3. Rest of Middle East & Africa Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

16.7.6.3.1. Anxiety

16.7.6.3.1.1. Panic Disorder

16.7.6.3.1.2. Social Anxiety Disorder

16.7.6.3.1.3. Obsessive Compulsive Disorder

16.7.6.3.1.4. Generalized Anxiety Disorder

16.7.6.3.1.5. Others

16.7.6.3.2. Depression

16.7.6.3.2.1. Major Depression

16.7.6.3.2.2. Persistent Depressive Disorder

16.7.6.3.2.3. Bipolar Disorder

16.7.6.3.2.4. Others

16.7.6.4. Rest of Middle East & Africa Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.7.6.4.1. Online

16.7.6.4.2. Offline

16.7.6.4.2.1. Hospitals/Clinics

16.7.6.4.2.2. Wellness Centers

16.7.6.4.2.3. Research Centers

16.7.6.4.2.4. Others

16.7.6.5. Rest of Middle East & Africa Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

16.7.6.5.1. Children

16.7.6.5.2. Adults

16.7.6.5.3. Senior Citizens

16.8. Key Segment for Channeling Investments

16.8.1. By Country

16.8.2. By Offerings

16.8.3. By Treatment Duration

16.8.4. By Form

16.8.5. By Distribution Channel

16.8.6. By Age Group

17. Latin America Anxiety and Depression Treatment Market Analysis and Forecasts, 2020 - 2028

17.1. Overview

17.1.1. Latin America Anxiety and Depression Treatment Market Revenue (US$ Mn)

17.2. Latin America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

17.2.1. Products

17.2.1.1. Benzodiazepine

17.2.1.2. Buspirone

17.2.1.3. Beta Blockers

17.2.1.3.1. Propranolol

17.2.1.3.2. Atenolol

17.2.1.3.3. Others

17.2.1.4. Others

17.2.2. Solutions

17.2.3. Services

17.2.3.1. Psychotherapy

17.2.3.1.1. Cognitive Behavioural Therapy (CBT)

17.2.3.1.2. Interpersonal Therapy (IPT)

17.2.3.1.3. Psychodynamic Therapy

17.2.3.1.4. Supportive Therapy

17.2.3.1.5. Others

17.2.3.2. Others

17.3. Latin America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

17.3.1. Short Term

17.3.2. Long Term

17.4. Latin America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

17.4.1. Anxiety

17.4.1.1. Panic Disorder

17.4.1.2. Social Anxiety Disorder

17.4.1.3. Obsessive Compulsive Disorder

17.4.1.4. Generalized Anxiety Disorder

17.4.1.5. Others

17.4.2. Depression

17.4.2.1. Major Depression

17.4.2.2. Persistent Depressive Disorder

17.4.2.3. Bipolar Disorder

17.4.2.4. Others

17.5. Latin America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

17.5.1. Online

17.5.2. Offline

17.5.2.1. Hospitals/Clinics

17.5.2.2. Wellness Centers

17.5.2.3. Research Centers

17.5.2.4. Others

17.6. Latin America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

17.6.1. Children

17.6.2. Adults

17.6.3. Senior Citizens

17.7. Latin America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Country

17.7.1. Brazil

17.7.1.1. Brazil Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

17.7.1.1.1. Products

17.7.1.1.1.1. Benzodiazepine

17.7.1.1.1.2. Buspirone

17.7.1.1.1.3. Beta Blockers

17.7.1.1.1.3.1. Propranolol

17.7.1.1.1.3.2. Atenolol

17.7.1.1.1.3.3. Others

17.7.1.1.1.4. Others

17.7.1.1.2. Solutions

17.7.1.1.3. Services

17.7.1.1.3.1. Psychotherapy

17.7.1.1.3.1.1. Cognitive Behavioural Therapy (CBT)

17.7.1.1.3.1.2. Interpersonal Therapy (IPT)

17.7.1.1.3.1.3. Psychodynamic Therapy

17.7.1.1.3.1.4. Supportive Therapy

17.7.1.1.3.1.5. Others

17.7.1.1.3.2. Others

17.7.1.2. Brazil Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

17.7.1.2.1. Short Term

17.7.1.2.2. Long Term

17.7.1.3. Brazil Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

17.7.1.3.1. Anxiety

17.7.1.3.1.1. Panic Disorder

17.7.1.3.1.2. Social Anxiety Disorder

17.7.1.3.1.3. Obsessive Compulsive Disorder

17.7.1.3.1.4. Generalized Anxiety Disorder

17.7.1.3.1.5. Others

17.7.1.3.2. Depression

17.7.1.3.2.1. Major Depression

17.7.1.3.2.2. Persistent Depressive Disorder

17.7.1.3.2.3. Bipolar Disorder

17.7.1.3.2.4. Others

17.7.1.4. Brazil Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

17.7.1.4.1. Online

17.7.1.4.2. Offline

17.7.1.4.2.1. Hospitals/Clinics

17.7.1.4.2.2. Wellness Centers

17.7.1.4.2.3. Research Centers

17.7.1.4.2.4. Others

17.7.1.5. Brazil Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

17.7.1.5.1. Children

17.7.1.5.2. Adults

17.7.1.5.3. Senior Citizens

17.7.2. Argentina

17.7.2.1. Argentina Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

17.7.2.1.1. Products

17.7.2.1.1.1. Benzodiazepine

17.7.2.1.1.2. Buspirone

17.7.2.1.1.3. Beta Blockers

17.7.2.1.1.3.1. Propranolol

17.7.2.1.1.3.2. Atenolol

17.7.2.1.1.3.3. Others

17.7.2.1.1.4. Others

17.7.2.1.2. Solutions

17.7.2.1.3. Services

17.7.2.1.3.1. Psychotherapy

17.7.2.1.3.1.1. Cognitive Behavioural Therapy (CBT)

17.7.2.1.3.1.2. Interpersonal Therapy (IPT)

17.7.2.1.3.1.3. Psychodynamic Therapy

17.7.2.1.3.1.4. Supportive Therapy

17.7.2.1.3.1.5. Others

17.7.2.1.3.2. Others

17.7.2.2. Argentina Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

17.7.2.2.1. Short Term

17.7.2.2.2. Long Term

17.7.2.3. Argentina Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

17.7.2.3.1. Anxiety

17.7.2.3.1.1. Panic Disorder

17.7.2.3.1.2. Social Anxiety Disorder

17.7.2.3.1.3. Obsessive Compulsive Disorder

17.7.2.3.1.4. Generalized Anxiety Disorder

17.7.2.3.1.5. Others

17.7.2.3.2. Depression

17.7.2.3.2.1. Major Depression

17.7.2.3.2.2. Persistent Depressive Disorder

17.7.2.3.2.3. Bipolar Disorder

17.7.2.3.2.4. Others

17.7.2.4. Argentina Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

17.7.2.4.1. Online

17.7.2.4.2. Offline

17.7.2.4.2.1. Hospitals/Clinics

17.7.2.4.2.2. Wellness Centers

17.7.2.4.2.3. Research Centers

17.7.2.4.2.4. Others

17.7.2.5. Argentina Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

17.7.2.5.1. Children

17.7.2.5.2. Adults

17.7.2.5.3. Senior Citizens

17.7.3. Rest of Latin America

17.7.3.1. Rest of Latin America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Offerings

17.7.3.1.1. Products

17.7.3.1.1.1. Benzodiazepine

17.7.3.1.1.2. Buspirone

17.7.3.1.1.3. Beta Blockers

17.7.3.1.1.3.1. Propranolol

17.7.3.1.1.3.2. Atenolol

17.7.3.1.1.3.3. Others

17.7.3.1.1.4. Others

17.7.3.1.2. Solutions

17.7.3.1.3. Services

17.7.3.1.3.1. Psychotherapy

17.7.3.1.3.1.1. Cognitive Behavioural Therapy (CBT)

17.7.3.1.3.1.2. Interpersonal Therapy (IPT)

17.7.3.1.3.1.3. Psychodynamic Therapy

17.7.3.1.3.1.4. Supportive Therapy

17.7.3.1.3.1.5. Others

17.7.3.1.3.2. Others

17.7.3.2. Rest of Latin America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Duration

17.7.3.2.1. Short Term

17.7.3.2.2. Long Term

17.7.3.3. Rest of Latin America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Form

17.7.3.3.1. Anxiety

17.7.3.3.1.1. Panic Disorder

17.7.3.3.1.2. Social Anxiety Disorder

17.7.3.3.1.3. Obsessive Compulsive Disorder

17.7.3.3.1.4. Generalized Anxiety Disorder

17.7.3.3.1.5. Others

17.7.3.3.2. Depression

17.7.3.3.2.1. Major Depression

17.7.3.3.2.2. Persistent Depressive Disorder

17.7.3.3.2.3. Bipolar Disorder

17.7.3.3.2.4. Others

17.7.3.4. Rest of Latin America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

17.7.3.4.1. Online

17.7.3.4.2. Offline

17.7.3.4.2.1. Hospitals/Clinics

17.7.3.4.2.2. Wellness Centers

17.7.3.4.2.3. Research Centers

17.7.3.4.2.4. Others

17.7.3.5. Rest of Latin America Anxiety and Depression Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group

17.7.3.5.1. Children

17.7.3.5.2. Adults

17.7.3.5.3. Senior Citizens

17.8. Key Segment for Channeling Investments

17.8.1. By Country

17.8.2. By Offerings

17.8.3. By Treatment Duration

17.8.4. By Form

17.8.5. By Distribution Channel

17.8.6. By Age Group

18. Competitive Benchmarking

18.1. Market Share Analysis

18.2. Global Presence and Growth Strategies

18.2.1. Mergers and Acquisitions

18.2.2. Product Launches

18.2.3. Investments Trends

18.2.4. R&D Initiatives

19. Player Profiles

19.1. Actiza Pharmaceutical Private Limited

19.1.1. Company Details

19.1.2. Company Overview

19.1.3. Product Offerings

19.1.4. Key Developments

19.1.5. Financial Analysis

19.1.6. SWOT Analysis

19.1.7. Business Strategies

19.2. Amwell

19.2.1. Company Details

19.2.2. Company Overview

19.2.3. Product Offerings

19.2.4. Key Developments

19.2.5. Financial Analysis

19.2.6. SWOT Analysis

19.2.7. Business Strategies

19.3. ANI Pharmaceuticals, Inc.

19.3.1. Company Details

19.3.2. Company Overview

19.3.3. Product Offerings

19.3.4. Key Developments

19.3.5. Financial Analysis

19.3.6. SWOT Analysis

19.3.7. Business Strategies

19.4. BetterHelp

19.4.1. Company Details

19.4.2. Company Overview

19.4.3. Product Offerings

19.4.4. Key Developments

19.4.5. Financial Analysis

19.4.6. SWOT Analysis

19.4.7. Business Strategies

19.5. eTherapyPro.com

19.5.1. Company Details

19.5.2. Company Overview

19.5.3. Product Offerings

19.5.4. Key Developments

19.5.5. Financial Analysis

19.5.6. SWOT Analysis

19.5.7. Business Strategies

19.6. F. Hoffmann-La Roche Ltd

19.6.1. Company Details

19.6.2. Company Overview

19.6.3. Product Offerings

19.6.4. Key Developments

19.6.5. Financial Analysis

19.6.6. SWOT Analysis

19.6.7. Business Strategies

19.7. Groop Internet Platform, Inc. (Talkspace)

19.7.1. Company Details

19.7.2. Company Overview

19.7.3. Product Offerings

19.7.4. Key Developments

19.7.5. Financial Analysis

19.7.6. SWOT Analysis

19.7.7. Business Strategies

19.8. MDLIVE Inc.

19.8.1. Company Details

19.8.2. Company Overview

19.8.3. Product Offerings

19.8.4. Key Developments

19.8.5. Financial Analysis

19.8.6. SWOT Analysis

19.8.7. Business Strategies

19.9. Pfizer Inc.

19.9.1. Company Details

19.9.2. Company Overview

19.9.3. Product Offerings

19.9.4. Key Developments

19.9.5. Financial Analysis

19.9.6. SWOT Analysis

19.9.7. Business Strategies

19.10. Teva Pharmaceuticals USA, Inc.

19.10.1. Company Details

19.10.2. Company Overview

19.10.3. Product Offerings

19.10.4. Key Developments

19.10.5. Financial Analysis

19.10.6. SWOT Analysis

19.10.7. Business Strategies

19.11. The Ross Center

19.11.1. Company Details

19.11.2. Company Overview

19.11.3. Product Offerings

19.11.4. Key Developments

19.11.5. Financial Analysis

19.11.6. SWOT Analysis

19.11.7. Business Strategies

19.12. Other Market Participants

20. Key Findings

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

**Exclusive for Multi-User and Enterprise User.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.

Prominent participants in our primary research process include:

Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

Reuters
Factiva
Bloomberg
One Source
Hoovers

Research Methodology

Key Inclusions

Request A Sample

Ask for Discount

Enquiry Before Buying

Request For Customization

Purchase Options

Single users $4600

Multi users $8200

Global users $9100

Buy Now

Reach to us

Call us on

+91-74002-42424

Drop us an email at

sales@absolutemarketsinsights.com